Dharti Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the agenda for reduction in ....
Awaiting price reaction for this filing.
Dharti Proteins Ltd has called a Board meeting on 13 February 2026 to consider a proposal for capital reduction, as required under the Resolution Plan approved by the NCLT Ahmedabad Bench on 18 November 2025. The company's paid-up share capital will be reduced from 1,02,77,200 equity shares of Rs. 10 each to just 5,00,000 equity shares of Rs. 10 each, bringing the total capital down to Rs. 50 lakh. Existing promoter shares will be fully cancelled (100%), while 4,25,000 shares will be issued to the Successful Resolution Applicant Mr. Jatinbhai Ramanbhai Patel and his group, 25,000 shares to existing public shareholders in proportion to their current holdings, and 50,000 shares to secured financial creditor Goenka Business & Finance Ltd. This is part of the implementation of the NCLT-approved resolution plan in CP (IB) No. 274 of 2023, effectively reconstituting the company under new management.
This is a major restructuring event: existing shareholders, especially promoters, will see 100% of their holdings wiped out, and public shareholders will receive only a tiny proportional allocation in the reconstituted company. The stock is likely to see sharp moves as the new shareholding structure takes effect and control shifts to the resolution applicant.